Connor McGogney, Chief Financial Officer of Criteo S.A. (NASDAQ:CRTO), filed a Form 4 on August 12, 2026, disclosing the acquisition of 23,090 ordinary shares on August 10, 2026, at a price of $0 per share.
Danielle E. Hunter, Executive Vice President, Chief Legal and Administrative Officer and Corporate Secretary of Centuri Holdings, Inc. (NYSE:CTRI), filed a Form 4 on August 12, 2026, disclosing the acquisition of restricted stock units under the company's Omnibus Incentive Plan.
A Form 4 filed on August 12, 2026 reported that Kelly Youngblood, Executive Vice President and Chief Financial Officer of Centuri Holdings, Inc. (NYSE:CTRI), received a grant of 72,864 restricted stock units under the company's Omnibus Incentive Plan.
Pershing Square Inc. filed a current report on August 12, 2026, disclosing its financial results for the second quarter ended June 30, 2026, along with a letter to shareholders from company leadership.
American Express Company filed a Form 8-K with the SEC on August 12, 2026, disclosing the issuance of 1,600,000 Depositary Shares representing a new series of preferred stock and announcing a planned full redemption of its existing Series D preferred securities.
Commercial Bancgroup, Inc. (NASDAQ:CBK), a Tennessee-based bank holding company, filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 12, 2026, covering the period ended June 30, 2026.
Silence Therapeutics plc filed a current report on Form 8-K on August 12, 2026, disclosing that it entered into an underwriting agreement on August 11, 2026, to sell American Depositary Shares in an underwritten public offering priced at $13.50 per ADS.
Cerebras Systems Inc. submitted its Form 10-Q for the quarterly period ended June 30, 2026, filed with the U.S. Securities and Exchange Commission and disclosing share counts, company structure, and operational context for the AI compute company.
GMR Solutions Inc. (NYSE:GMRS) filed its Form 10-Q for the quarterly period ended June 30, 2026 with the Securities and Exchange Commission, disclosing condensed consolidated financial statements and related notes as of that date.
M Evo Global Acquisition Corp II filed its quarterly report on Form 10-Q for the quarter ended June 30, 2026, disclosing results following the completion of its Initial Public Offering earlier in the year.